• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Osiris Therapeutics Inc

+ Add to Watchlist


14.4300 USD 0.1000 0.70%

As of 15:01:51 ET on 12/22/2014.

Snapshot for Osiris Therapeutics Inc (OSIR)

Open: 14.3000 Day's Range: 13.7500 - 14.4700 Volume: 57,993
Previous Close: 14.3300 52wk Range: 11.8004 - 18.4100 1-Yr Rtn: -14.21%

Stock Chart for OSIR

No chart data available.
  • OSIR:US 14.3700
  • 1D
  • 1M
  • 1Y
Interactive OSIR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OSIR

Current P/E Ratio (ttm) 244.0190
Estimated P/E(12/2014) -
Relative P/E vs. SPX 13.3698
Earnings Per Share (USD) (ttm) 0.0587
Est. EPS (USD) (12/2014) -0.0550
Est. PEG Ratio -
Market Cap (M USD) 491.27
Shares Outstanding (M) 34.32
30 Day Average Volume 103,487
Price/Book (mrq) 6.0059
Price/Sale (ttm) 10.1068
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OSIR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OSIR

Osiris Therapeutics, Inc. researches and develops therapeutic products for the regeneration of human connective tissues. The Company is focusing its initial product development efforts on the regeneration of bone marrow stroma following high-dose cancer chemotherapy, and on the regeneration of bone in long bone and spinal defects.

Lode DebrabanderePresident/CEOPhilip R Jacoby JrCFO/Treasurer/Secretary
Jonathan M Hopper "Jon"Chief Medical OfficerFrank D Czworka JrVP/General Manager:Wound Care
More Company Profile & Key Executives for OSIR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil